Literature DB >> 10221693

Perinatal outcome after in-vitro fertilization-surrogacy.

J Parkinson1, C Tran, T Tan, J Nelson, J Batzofin, P Serafini.   

Abstract

The perinatal outcome of pregnancies (both single and multiple) established after in-vitro fertilization (IVF)-surrogacy was evaluated and compared to the outcome of pregnancies that resulted from standard IVF. Analysis of medical records and a telephone interview with physicians, IVF-surrogates, and commissioning mothers were conducted to assess prenatal follow up and delivery care in several hospitals. 95 IVF-surrogates delivered 128 liveborn (65 singletons, 27 sets of twins and two sets of triplets). The commissioning mothers and the IVF-surrogates average ages were 37.7 +/- 5.0 and 30.4 +/- 4.7 years old respectively. IVF-surrogates carrying twin and triplet gestations delivered substantially earlier than those who gestated singleton pregnancies (36.2 +/- 0.4 versus 35.5 versus 38.7 +/- 0.3 weeks gestation respectively; P < 0.001). Twin newborns were significantly lighter than singleton infants born through IVF-surrogacy (2.7 +/- 0.06 versus 3.5 +/- 0.07 kg; P < 0.001). The incidence of low birth weight infants rose from 3.3% in the single births to 29.6% (P < 0.01) in the twins and to 33.3% in the triplets born through IVF-surrogacy. The incidence of prematurity was significantly greater in both twins delivered by IVF-surrogates (20.4%) and infertile IVF patients (58%). The occurrence of pregnancy-induced hypertension and bleeding in the third trimester was four to five times lower in the IVF-surrogates, independently of whether they were carrying multiples. The incidence of Caesarean section was 21.3% for singleton gestations, while two times higher in the IVF-surrogates carrying multiples (56.3%). Postpartum complications occurred in 6.3% of patients and the incidence of malformation was similar to those reported for the general population. The results provide general reassurance regarding perinatal outcome to couples who wish to pursue IVF-surrogacy.

Entities:  

Mesh:

Year:  1999        PMID: 10221693     DOI: 10.1093/humrep/14.3.671

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

Review 1.  Might uterus transplantation be an option for uterine factor infertility?

Authors:  Münire Erman Akar
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-03-01

Review 2.  Surrogate pregnancy: a guide for Canadian prenatal health care providers.

Authors:  Dan R Reilly
Journal:  CMAJ       Date:  2007-02-13       Impact factor: 8.262

3.  Reduction in multiple pregnancy rate in donor oocyte-recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the USA with single-embryo transfer and preimplantation genetic testing.

Authors:  Reeva Makhijani; Madeline Coulter; Arti Taggar; Prachi Godiwala; David O'Sullivan; John Nulsen; Lawrence Engmann; Claudio Benadiva; Daniel Grow
Journal:  J Assist Reprod Genet       Date:  2021-03-11       Impact factor: 3.357

4.  Present state of reproductive medicine in Japan - ethical issues with a focus on those seen in court cases.

Authors:  Mayumi Mayeda
Journal:  BMC Med Ethics       Date:  2006-04-05       Impact factor: 2.652

5.  Gestational carriers: A viable alternative for women with medical contraindications to pregnancy.

Authors:  Raymond M Anchan; Stacey A Missmer; Katharine F Correia; Elizabeth S Ginsburg
Journal:  Open J Obstet Gynecol       Date:  2013-07-01

6.  Emotional experiences in surrogate mothers: A qualitative study.

Authors:  Hoda Ahmari Tehran; Shohreh Tashi; Nahid Mehran; Narges Eskandari; Tahmineh Dadkhah Tehrani
Journal:  Iran J Reprod Med       Date:  2014-07

Review 7.  Risks in Surrogacy Considering the Embryo: From the Preimplantation to the Gestational and Neonatal Period.

Authors:  M Simopoulou; K Sfakianoudis; P Tsioulou; A Rapani; G Anifandis; A Pantou; S Bolaris; P Bakas; E Deligeoroglou; K Pantos; M Koutsilieris
Journal:  Biomed Res Int       Date:  2018-07-17       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.